Skip to main content

Opko Health, Inc.

OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000944809

In the last 90 days, Opko Health, Inc. insiders filed 0 open-market purchases and 1 sale; 225 institutions reported holding it in 13F filings for Q3 2026, worth $324.4M in total; no superinvestor holds it.

Holders of 5% or more of OPK

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Opko Health, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of OPK
HolderLatest formStakeChangeFirst filedLatest filingFiling
Frost Phillip MD Et Al13D/A34.10%255.4M shares+1.30 ppfrom 32.80%Aug 19, 20229 filingsJul 1, 2026SEC
Rubric Capital Management LP13G/A6.03%47.8M shares–Nov 13, 20242 filingsJul 9, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

25 Schedule 13D and 13G filings on Opko Health, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on OPK
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 1, 20264:04 PM ETFrost Phillip MD Et Aland 2 others13D/A34.10%255.4M shares+1.30 ppfrom 32.80%Jun 29, 2026SEC
Oct 1, 20254:46 PM ETFrost Phillip MD Et Aland 2 others13D/A32.80%252.9M shares+1.10 ppfrom 31.70%Sep 30, 2025SEC
Jul 9, 20254:10 PM ETRubric Capital Management LPand 1 other13G/A6.03%47.8M shares–Jun 30, 2025SEC
Apr 3, 20255:22 PM ETFrost Phillip MD Et Aland 2 others13D/A31.70%252.4M shares–Apr 2, 2025SEC
Apr 3, 20255:21 PM ETHsiao Jane PH Dand 1 other13D/A4.50%35.7M shares–Below 5%Apr 2, 2025SEC
Nov 15, 2024Frost Phillip MD Et Al13D/AOld format–––SEC
Nov 13, 2024Rubric Capital Management LP13GOld format–New–SEC
Nov 12, 2024Vanguard Group Inc13G/AOld format–––SEC
Nov 4, 2024Vanguard Group Inc13G/AOld format–––SEC
Aug 29, 2024Frost Phillip MD Et Al13D/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Jan 24, 2024Hsiao Jane PH D13D/AOld format–––SEC
Jan 24, 2024Frost Phillip MD Et Al13D/AOld format–––SEC
Jan 22, 2024Frost Phillip MD Et Al13D/AOld format–––SEC
Feb 21, 2023Frost Phillip MD Et Al13D/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Aug 19, 2022Hsiao Jane PH D13D/AOld format–––SEC
Aug 19, 2022Frost Phillip MD Et Al13D/AOld format–––SEC
Jun 29, 2022Zerhouni Elias A.13DOld format–New–SEC
Jun 29, 2022Nabel Gary J.13DOld format–New–SEC
Mar 9, 20225:18 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 1, 20225:08 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Jan 29, 20215:23 PM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Opko Health, Inc. shares.

No Form 144 notices for Opko Health, Inc. are on file.